NATICK, Mass., April 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced that it has completed its combination with Guidant Corporation (NYSE:GDT), creating a...
- Combination of Abbott's and Guidant's Vascular Organizations Creates Leading Vascular Devices Business - ABBOTT PARK, Ill., April 21 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) today announced...
Transaction scheduled to close tomorrow NATICK, Mass., April 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced it has received antitrust approval from the...
NEW YORK, April 11 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 on a date to be announced: * S&P MidCap 400...
NATICK, Mass., April 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced that it has received antitrust clearance from the European Commission regarding its...
Agreement subject to approval by FTC Commissioners NATICK, Mass., April 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into an agreement...
Guidant Corporation (NYSE:GDT) today announced preliminary, unaudited first quarter revenues of approximately $894 million, reflecting a decline of approximately 6 percent versus the first quarter...
NATICK, Mass. and INDIANAPOLIS, March 31 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) and Guidant Corporation (NYSE:GDT) today announced that the shareholders of each...
Guidant Corporation (NYSE:GDT) today announced that a small percentage (approximately 1 percent) of the current XIENCE V inventory was not manufactured with strict adherence to its...
NATICK, Mass., March 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced that it has made certain commitments to the Directorate-General for Competition of the...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約